Statistics

Total Visits

Views
Cabazitaxel in patients with advanced CRPC after Docetaxel-Failure. Results of expanded Program access(EAP) in Spain: Safety and efficacy.108

Select a period of time:

Number of views in the range

Views
Cabazitaxel in patients with advanced CRPC after Docetaxel-Failure. Results of expanded Program access(EAP) in Spain: Safety and efficacy.57

Views

Views
December 20253
January 202610
February 20263
March 20269
April 20268
May 202610
June 202614
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States34
Netherlands8
United Kingdom3
Germany3
Venezuela2
Canada1
Côte d'Ivoire1
Egypt1
Finland1
Mexico1
 

Top cities views

Views
San Jose15
Groningen8
Ashburn4
10th of Ramadan City1
Birmingham1
Caledon1
Frankfurt am Main1
Grajales1
Helsinki1
Los Angeles1